Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients
Language English Country Germany Media print-electronic
Document type Evaluation Study, Journal Article, Multicenter Study
PubMed
29575150
DOI
10.1111/myc.12765
Knihovny.cz E-resources
- Keywords
- (1,3)-β-d-glucan, A. fumigatus-specific IgA, IgG, galactomannan, invasive pulmonary aspergillosis, non-neutropenic patients,
- MeSH
- Aspergillus fumigatus chemistry immunology MeSH
- beta-Glucans blood MeSH
- Adult MeSH
- Galactose analogs & derivatives MeSH
- Immunoglobulin A blood MeSH
- Immunoglobulin G blood MeSH
- Invasive Pulmonary Aspergillosis diagnosis MeSH
- Middle Aged MeSH
- Humans MeSH
- Mannans blood MeSH
- Adolescent MeSH
- Young Adult MeSH
- Predictive Value of Tests MeSH
- Proteoglycans MeSH
- Antibodies, Fungal blood MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Sensitivity and Specificity MeSH
- Serum chemistry MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Multicenter Study MeSH
- Names of Substances
- beta-Glucans MeSH
- galactomannan MeSH Browser
- Galactose MeSH
- Immunoglobulin A MeSH
- Immunoglobulin G MeSH
- Mannans MeSH
- polysaccharide-K MeSH Browser
- Proteoglycans MeSH
- Antibodies, Fungal MeSH
Detection of serum galactomannan (GM) and (1,3)-β-d-glucan (BG) is considered useful for non-culture diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients. Only few studies evaluated these seromarkers in non-neutropenic patients suspected of having IPA. The aim of this study was to evaluate both tests together with the Aspergillus fumigatus-specific serum IgG and IgA (IgAG) test for serological IPA diagnosis in non-neutropenic patients. Sera from 87 patients suspected of having IPA were retrospectively analysed. Patients were categorised into groups of proven IPA (n = 10), putative IPA (n = 31) and non-IPA colonisation (n = 46). When the GM, BG and IgAG assays were used for patients included in the study, the sensitivity/specificity/positive predictive value (PPV)/negative predictive value (NPV) were 48.8%/91.3%/83.3%/66.7%, 82.9%/73.9%/73.9%/82.9% and 75.6%/95.7%/93.9%/81.5%, respectively. Thus, the highest specificity and PPV were confirmed for the IgAG assay. Improvements in the sensitivity and NPV were achieved by "at least one positive" analysis with the GM and BG assays, with the sensitivity/specificity/PPV/NPV values being 85.0%/69.6%/71.4%/84.2%. Nevertheless, the highest sensitivity and NPV were achieved by the "at least one positive" analysis combining the GM, BG and IgAG tests (97.6% and 96.8%, respectively). The involvement of the IgAG assay could improve IPA diagnosis in non-neutropenic patients by increasing the sensitivity and NPV when combined with the GM or BG assays. Furthermore, improvement was achieved by combining the GM, BG and IgAG assays using the "at least one positive test" strategy, especially if doubt exists.
Center of Health Services Institute of Public Health in Ostrava Ostrava Czech Republic
Lung Department Krnov Combined Medical Facility Krnov Czech Republic
References provided by Crossref.org
Current and Future Pathways in Aspergillus Diagnosis
Diagnosis of Aspergillosis in Horses